---
schema_version: "secwatch.filing_event.v1"
accession: "0001402479-23-000023"
form_type: "8-K/A"
ticker: null
cik: "0001402479"
company_name: "MedAvail Holdings, Inc."
filed_at: "2023-04-06T23:59:59+00:00"
generated_at: "2026-06-17T05:03:44.428467+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MedAvail substantially completes exit from pharmacy services; focuses on pharmacy tech business

## Summary
- As of March 31, 2023, MedAvail substantially completed exit from pharmacy services; future focus solely on pharmacy tech.
- Closed asset sale to CVS on Feb 10, 2023 for $2.9M final purchase price (up to $4.4M originally) with $0.1M fees and $0.2M holdback.
- Pro forma shows elimination of pharmacy services revenue: $30.7M for 9mo Sep2022, $20.2M for FY2021.
- Pro forma net loss reduced to $15.4M (9mo Sep2022) from historical $36.5M; discontinued ops treatment in Q1 2023 10-Q.
- Company now solely a pharmacy technology business after exiting retail pharmacy operations.

## SEC filing metadata
- accession: 0001402479-23-000023
- form_type: 8-K/A
- cik: 0001402479
- company_name: MedAvail Holdings, Inc.
- filed_at: 2023-04-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 9.01, 2.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402479/000140247923000023/0001402479-23-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402479/000140247923000023/medavail-20230118.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001402479-23-000023
- JSON: https://secwatch.observer/filing/0001402479-23-000023.json
- Plain text: https://secwatch.observer/filing/0001402479-23-000023.txt

## Key facts
- M&A Transactions
  MedAvail Holdings, Inc. completed a disposition involving German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, "CVS") for final purchase price of $2.9 million (closed 2023-02-10).
  - Action: disposition
  - Counterparty: German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, "CVS")
  - Consideration: final purchase price of $2.9 million
  - Closing: 2023-02-10
  source text: On February 10, 2023, the Company closed the CVS Transaction for a final purchase price of $2.9 million; subject to $0.1 million fees and a $0.2 million holdback.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402479/000140247923000023/0001402479-23-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.